论文部分内容阅读
A planar copper complex Cu(L)2,HL=(E)-benzyl-2-(4-formylbenzylidene)-Hydrazinecarbodithioate,has been prepared via the template effect of copper ion. Crystal structure of the complex was determined by X-ray singlecrystal diffraction analysis. The crystal data for this complex:Orthorhombic,space group Pbcn,a=2.250 0(14) nm,b=1.660 0(11) nm,c=0.830 4(5) nm,V=3.102(3) nm3,Z=4,μ=1.011 mm-1,Dc=1.478 g·cm-3,F(000)=1 420,R1= 0.050 1,wR2=0.087 2 (observed reflections with I>2σ(I)) and R1=0.129 1,wR2=0.100 9 (all reflections) GOF= 1.011. In the compound,Cu(Ⅱ) atom is four-coordinated with two N atoms and two S atoms from two bidentate ligands and located in the inversion center. The preliminary bioassay indicates that the complex exhibits distinct antitumor activity.
A planar copper complex Cu (L) 2, HL = (E) -benzyl-2- (4-formylbenzylidene) -Hydrazinecarbodithioate, has been prepared via the template effect of copper ion. Crystal structure of the complex was determined by X-ray singlecrystal diffraction analysis. The crystal data for this complex: Orthorhombic, space group Pbcn, a = 2.250 0 (14) nm, b = 1.660 0 (11) nm, c = 0.830 4 nm, Z = 4, μ = 1.011 mm -1, Dc = 1.478 g · cm -3, F (000) = 1 420, R1 = 0.050 1, wR2 = 0.087 2 (observed reflections with I> 2σ (I)) and R1 = 0.129 1, wR2 = 0.1009 (all reflections) GOF = 1.011. In the compound, Cu (II) atom is four- coordinated with two N atoms and two S atoms from two bidentate ligands and located in the inversion center. The preliminary bioassay says that the complex exhibits distinct antitumor activity.